Health of the Human MicrobiomePhase 2NCT02343731
Dogs as Probiotics
A Phase 2 study testing Introduction of a dog into the home in people with Health of the Human Microbiome, run by University of Arizona at 1 site in United States.
Trial summary
Studies show that family members share as much or more of the composition of their microbiota (the trillions of micro-organisms in our guts) with their dogs as they do with each other (Song et. al. 2013). This shows that the introduction of dogs into home environments has a profound impact on the human microbiota. Read more about this study
- Who is it for?
- Ages 50 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- Health of the Human Microbiome
- What is being tested?
- Introduction of a dog into the home
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 20 participants
- Where
- 1 siteUnited States
- Study dates
- Jan 2015to Sep 2015
- Phase
- Phase 2
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 50 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Male or females aged 50 - 80.
- In general good health (mobile and able to care for a dog).
- Have not taken antibiotics in the last six months.
- Have not had a dog in the home for the past six months.
- Able to understand the nature of the study and able to provide written informed consent prior to conduct of any study procedures.
- Able to communicate in English with study personnel.
- Willing to commit to fostering a dog for at least three months with the understanding that at the end of the three months, they can keep the dog if they so desire.
Who cannot join
- Individuals who are currently on any antibiotic therapy. Participants who are on an antibiotic therapy will be allowed to participate in the study after a six month washout period.
- Unwilling to have a dog in the home for at least three months of time.
- Any of the following diagnoses, as identified by the intake evaluation conducted or study assessments:
- o History of any of the following mental illnesses: schizophrenia, bipolar I disorder, drug or alcohol abuse active within 6 months of study entry. Determination of these criteria will be by self-report at screening interview
- Subject has a medical condition or disorder that:
- Is unstable and clinically significant, or:
Show all 13Show fewer
- Specifically impact immune functioning of the GI tract including Crohn's disease and ulcerative colitis
- Require either chronic or periodic antibiotic treatment
- Could interfere with the accurate assessment of safety or efficacy of the clinical assessments, including:
- Individuals with any:
- o Current participation in any clinical trial that might impact results of this one, which includes participation in another clinical trial where any experimental drugs are being taken as well as studies / drug trials with agents that might affect mood and or the gastrointestinal tract.
- Reasonable likelihood for non-compliance with the protocol for any other reason, in the opinion of the Investigator, prohibits enrollment of subject into the study.
- Any clinically significant autoimmune disease (compensated hypothyroidism allowed)
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Dogs as Probiotics to Enhance the Health and Emotional Well-Being of Elderly Adults
Studies show that family members share as much or more of the composition of their microbiota (the trillions of micro-organisms in our guts) with their dogs as they do with each other (Song et. al. 2013). This shows that the introduction of dogs into home environments has a profound impact on the human microbiota. Additionally, many studies show that children raised with dogs are less likely than others to develop a range of immune-mediated disorders, including asthma and allergies (Ownby, Johnson, and Peterson 2002; Almqvist et al. 2003; Havstad et al. 2011). This suggests that dogs can serve as probiotics for children by appropriately training their immune systems not to produce inflammation in response to harmless stimuli. What is not known, however, is whether the same is true for elderly populations and dogs. Thus, this study seeks to explore whether dogs might also improve the physical and mental health of elderly adults by improving the structure and function of their microbiota. The investigators propose a pilot/proof of concept study to investigate whether dogs might improve the physical and mental health of elderly adults via changing (improving) the structure and function of their microbiota (gut flora). The investigators propose a pre-post study design that among 20 elderly individuals (aged 50 and older) to investigate the probiotic effect that dogs might have on these individuals. The investigators are particularly interested to know whether introducing a dog into a home where one has not lived in the recent past increases the "positive" microorganisms in the guts of the humans living with them. The investigators will also measure the changes in markers of inflammation (from blood samples) as well as the changes in self-reported scores of depression, frailty, physical activity, and general health and well-being mobility among human participants. In order to assess any effects in the animal study participants, the investigators will also collect and analyze fecal and blood samples as well as conduct home visits to observe canine and human interactions and bonding and conduct assessments of canine well-being using questionnaires/observational techniques that have been validated for these purposes in other studies. Additionally, the investigators will assess the interactions between of the participants with the dog and how having a dog in the home may influence an individual's relationship with the dog and his/her thoughts about the microbiota, human and canine health and human-animal interactions through monthly semi-structured interviews.
The investigators have previously received IACUC approval for this study, approval number 14-537.
Read the detailed description
One of the most amazing scientific discoveries of the last decade has been the important roles that the trillions of micro-organisms in our guts (called the "microbiota") play in promoting good physical health and emotional well-being. Unfortunately, many aspects of the modern world conspire to alter the composition and function of the gut microbiota in ways that damage health, especially in the elderly where strong correlations have been seen between microbiota composition and frailty. Work from our research group and others suggests that one very important factor that damages the microbiota in the modern world is our separation from many micro-organisms with which the investigators co-evolved and which have the ability to lower the types of chronic inflammation that are ubiquitous in the modern world and that contribute to the development of most of our most pressing health issues, from diabetes and heart disease to depression and dementia (Huang et al., 2013; Mayer et al, 2014; Naseribafrouei, 2013). While much has been written about the positive psycho-social impacts that animal-human relationships have on human psychological health (Allen et al, 1991; Allen et al.; 2002; Collins et al, 2006; Kwong \& Bartholomew, 2011; Kurdek, 2008; Wells, 2007), less is known about the direct physical effects that animals have on human health. What is known, however, is largely related to animals' effects on stress reduction (Allen et al, 1991; Allen et al., 2002) anxiety (Foster \& McVey Neufeld, 2013), mood (Collins et al, 2006) and cardiovascular disease (Allen et al., 2002) What has been largely unexplored, however, is the mechanism by which these interactions and positive impacts on human health are taking place. Thus, working with colleagues who are world leaders in studying links between the microbiota and health, the investigators propose to conduct a study designed to explore the potential of dogs to serve as "probiotic delivery systems" to enhance the physical health and cognitive and emotional functioning of at-risk elderly persons.
The rationale for this novel approach to enhancing health and well-being in the elderly comes from several lines of evidence. First, one recent study shows that family members share as much or more of the composition of their microbiota with their dogs as they do with each other (Song et al. 2013). This shows that the introduction of dogs into home environments has a profound impact on the human microbiota. Second, many studies show that children raised with dogs are less likely than others to develop a range of immune-mediated disorders, including asthma and allergies (Ownby et al. 2002; Almqvist et al. 2003; Havstad et al. 2011). This suggests that dogs can serve as probiotics for children by appropriately training their immune systems not to produce inflammation in response to harmless stimuli. Thus, what is not known, and what this study is designed to explore, is whether dogs might also improve the physical and mental health of elderly adults by improving the structure and function of their microbiota. This is a proof of concept / pilot study. Should results from this study suggest that there is indeed a positive benefit/relationship to canine companionship to the microbiota of elderly human companions, the investigators plan to implement a larger, full-scale clinical trial to investigate this phenomenon.
Hypothesis: The investigators hypothesize that the introduction of a canine companion into the home of an elderly individual (defined as aged 50 and older) will result in an increase in protective or 'positive' gut micro-organisms and that this increase will correspond with improved immune functioning in the elderly human study participants.
- Conditions
- Health of the Human Microbiome
- Being tested
- Introduction of a dog into the home
- Keywords
- microbiome, hygiene hypothesis, human-animal interaction, microbiota, connections between human-canine microbiome
- Medical subject headings
- Human-Animal Interaction
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Introduction of a dog into the homeOther
Participants will foster dogs from the HSSA for three months while they are in the study.
| Study group | Role | What they receive |
|---|---|---|
| Dog Introduction | Experimental | Participants will receive a dog from the Humane Society of Southern Arizona's (HSSA) foster care program to live with them for three months. Receives: Other: Introduction of a dog into the home |
What is being measured
The primary outcome is the main question the study is designed to answer.
Increase in positive microbiota in humans
To examine the degree to which the positive microbiota increase in human study participants' guts from baseline to three months. We will do this by collecting the human participants' saliva, skin and feces.
Measured: Seven days prior to the intervention, Day 0, Day 30, Day 60 and Day 90
Correlation between positive microbiota changes and immune function changes
To examine the correlations between positive microbiota changes in the human gut after introduction of a canine companion with any changes in immune and related molecules that have been linked to emotional well-being. We will do this by collecting blood from the human participants.
Measured: Seven days prior to the intervention, Day 0, Day 30, Day 60 and Day 90
Secondary outcomes (16)
Change in human physical activity over time
The study participant will wear a non-invasive Actigraph GT3X+ device which clips to the waistbelt for 7 consecutive days at 4 time points in the study. The accelerometer is small (1.5x2 inches) and will be clipped to the waistband/belt.
Measured: Seven days prior to the intervention, Day 0, Days 23-30, Days 53-60 and Days 83-90
Change in dog physical activity over time
Whistle monitors are pet activity monitors that dogs can wear around their necks, attached to their dog collars. Whistle monitors come with a built-in accelerometer that senses the animal's movement. The accelerometer measures steps taken, distance walked, and overall activity duration and intensity every 30 seconds.
Measured: Seven days prior to the intervention, Day 0, Days 23-30, Days 53-60 and Days 83-90
Change in heart rate variability over time
Heart Rate Variability (HRV) will be assessed over time to see if having a dog significantly impacts HRV. HRV will be assessed during the period of SCL collection and will be calculated using both time and frequency domain methodologies.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in frailty score over time
The Fried Frailty test will be administered and changes in participants overall schedule will be assessed and compared over time.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in body fat composition over time
Measured: Day 0, Day 30, Day 60 and Day 90
Change in Score on the Q-LESQ-SF (Quality of Life Enjoyment and Satisfaction Questionnaire -Short form)
Percent change in scores between baseline and subsequent assessments will be assessed to determine the effect of dog ownership on self-reported quality of life.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in score on the WHO-5
Percent change in scores between baseline and subsequent visits on the WHO-5, to assess the effect of dog ownership on current well being.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in depression scores over time [Inventory of Depressive Symptomatology-Self Report (IDS-SR)]
Percent change in scores between baseline and subsequent assessments will be assessed to determine the effect of dog ownership on any depression symptoms.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time Short Form-36
Percent change in the SF-36, a standard health questionnaire that assesses dog ownerships effect on overall physical health and emotional well-being.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the UCLA Loneliness Scale
Percent change in scores on the UCLA Loneliness Scale to assess the effect of dog ownership on loneliness.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Mini-Cognition Test
Percent change in scores on the Mini-Cognition Test to assess the effect of dog ownership on cognition over time.
Measured: Day 0, Day 30, Day 60 and Day 90
Change is scores over time on the International Physical Activity Questionnaire (IPAQ)
Percent change in scores on the Physical Activity Questionnaire (IPAQ) is a short standard questionnaire to assess the effect of dog ownership on physical activity.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Dogs and Physical Activity Tool (DAPA)
Percent change in scores on the DAPA to assess effect of dog ownership on dog physical activity.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Dog Quality of Life Scale
Percent change in scores on the Dog Quality of Life Scale to assess the effect of dog ownership on a dog's quality of life.
Measured: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Lexington Human Animal Bond (HAB)
Percent change in scores on the HAB measure to assess how the human animal bond changes over the study period.
Measured: Day 0, Day 30, Day 60 and Day 90
Interviews
The topics to be covered in the interview will include a discussion of previous dog/animal ownership, thoughts and feelings on the animal-human bond, understandings of the microbiota, animal-human microbiota connections and intersections between animals, humans and scientific understandings of the body and medicine.
Measured: Day 0, Day 30, Day 60 and Day 90
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Jan 2015 (estimated)
- Study startJan 2015
- Primary completionSep 2015
- Study completionSep 2015
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Health of the Human MicrobiomeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Arizona
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Ole Thienhaus, University of Arizona
- Investigators
- Charles Raison, MD, Study director, University of Arizona, Department of Psychiatry, College of MedicineOle Thienhaus, MD, Principal investigator, University of Arizona, Department of Psychiatry, College of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02343731
- Sponsor's protocol ID
- Pending NCT02343731
- Status last verified
- Jan 2016
- First submitted
- 13 Jan 2015
- Last updated
- 12 Jan 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 12 Jan 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Dogs as Probiotics to Enhance the Health and Emotional Well-Being of Elderly Adults
- ClinicalTrials.gov ID
- NCT02343731
- Acronym / sponsor ID
- Pending NCT02343731
- Conditions
- Health of the Human Microbiome
- Keywords
- microbiome, hygiene hypothesis, human-animal interaction, microbiota, connections between human-canine microbiome
- Phase
- Phase 2
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of ArizonaUniversity, hospital or other
- Study start
- Jan 2015
- Primary completion
- Sep 2015 (actual)
- Study completion
- Sep 2015 (actual)
- First posted
- 22 Jan 2015 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Studies show that family members share as much or more of the composition of their microbiota (the trillions of micro-organisms in our guts) with their dogs as they do with each other (Song et. al. 2013). This shows that the introduction of dogs into home environments has a profound impact on the human microbiota. Additionally, many studies show that children raised with dogs are less likely than others to develop a range of immune-mediated disorders, including asthma and allergies (Ownby, Johnson, and Peterson 2002; Almqvist et al. 2003; Havstad et al. 2011). This suggests that dogs can serve as probiotics for children by appropriately training their immune systems not to produce inflammation in response to harmless stimuli. What is not known, however, is whether the same is true for elderly populations and dogs. Thus, this study seeks to explore whether dogs might also improve the physical and mental health of elderly adults by improving the structure and function of their microbiota. The investigators propose a pilot/proof of concept study to investigate whether dogs might improve the physical and mental health of elderly adults via changing (improving) the structure and function of their microbiota (gut flora). The investigators propose a pre-post study design that among 20 elderly individuals (aged 50 and older) to investigate the probiotic effect that dogs might have on these individuals. The investigators are particularly interested to know whether introducing a dog into a home where one has not lived in the recent past increases the "positive" microorganisms in the guts of the humans living with them. The investigators will also measure the changes in markers of inflammation (from blood samples) as well as the changes in self-reported scores of depression, frailty, physical activity, and general health and well-being mobility among human participants. In order to assess any effects in the animal study participants, the investigators will also collect and analyze fecal and blood samples as well as conduct home visits to observe canine and human interactions and bonding and conduct assessments of canine well-being using questionnaires/observational techniques that have been validated for these purposes in other studies. Additionally, the investigators will assess the interactions between of the participants with the dog and how having a dog in the home may influence an individual's relationship with the dog and his/her thoughts about the microbiota, human and canine health and human-animal interactions through monthly semi-structured interviews.
The investigators have previously received IACUC approval for this study, approval number 14-537.
Detailed description
One of the most amazing scientific discoveries of the last decade has been the important roles that the trillions of micro-organisms in our guts (called the "microbiota") play in promoting good physical health and emotional well-being. Unfortunately, many aspects of the modern world conspire to alter the composition and function of the gut microbiota in ways that damage health, especially in the elderly where strong correlations have been seen between microbiota composition and frailty. Work from our research group and others suggests that one very important factor that damages the microbiota in the modern world is our separation from many micro-organisms with which the investigators co-evolved and which have the ability to lower the types of chronic inflammation that are ubiquitous in the modern world and that contribute to the development of most of our most pressing health issues, from diabetes and heart disease to depression and dementia (Huang et al., 2013; Mayer et al, 2014; Naseribafrouei, 2013). While much has been written about the positive psycho-social impacts that animal-human relationships have on human psychological health (Allen et al, 1991; Allen et al.; 2002; Collins et al, 2006; Kwong \& Bartholomew, 2011; Kurdek, 2008; Wells, 2007), less is known about the direct physical effects that animals have on human health. What is known, however, is largely related to animals' effects on stress reduction (Allen et al, 1991; Allen et al., 2002) anxiety (Foster \& McVey Neufeld, 2013), mood (Collins et al, 2006) and cardiovascular disease (Allen et al., 2002) What has been largely unexplored, however, is the mechanism by which these interactions and positive impacts on human health are taking place. Thus, working with colleagues who are world leaders in studying links between the microbiota and health, the investigators propose to conduct a study designed to explore the potential of dogs to serve as "probiotic delivery systems" to enhance the physical health and cognitive and emotional functioning of at-risk elderly persons.
The rationale for this novel approach to enhancing health and well-being in the elderly comes from several lines of evidence. First, one recent study shows that family members share as much or more of the composition of their microbiota with their dogs as they do with each other (Song et al. 2013). This shows that the introduction of dogs into home environments has a profound impact on the human microbiota. Second, many studies show that children raised with dogs are less likely than others to develop a range of immune-mediated disorders, including asthma and allergies (Ownby et al. 2002; Almqvist et al. 2003; Havstad et al. 2011). This suggests that dogs can serve as probiotics for children by appropriately training their immune systems not to produce inflammation in response to harmless stimuli. Thus, what is not known, and what this study is designed to explore, is whether dogs might also improve the physical and mental health of elderly adults by improving the structure and function of their microbiota. This is a proof of concept / pilot study. Should results from this study suggest that there is indeed a positive benefit/relationship to canine companionship to the microbiota of elderly human companions, the investigators plan to implement a larger, full-scale clinical trial to investigate this phenomenon.
Hypothesis: The investigators hypothesize that the introduction of a canine companion into the home of an elderly individual (defined as aged 50 and older) will result in an increase in protective or 'positive' gut micro-organisms and that this increase will correspond with improved immune functioning in the elderly human study participants.
Study design
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Dog Introduction | Experimental | Other: Introduction of a dog into the homeParticipants will receive a dog from the Humane Society of Southern Arizona's (HSSA) foster care program to live with them for three months. |
Who may qualify
- Ages
- 50 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (7 listed)
- Male or females aged 50 - 80.
- In general good health (mobile and able to care for a dog).
- Have not taken antibiotics in the last six months.
- Have not had a dog in the home for the past six months.
- Able to understand the nature of the study and able to provide written informed consent prior to conduct of any study procedures.
Key exclusion criteria (13 listed)
- Individuals who are currently on any antibiotic therapy. Participants who are on an antibiotic therapy will be allowed to participate in the study after a six month washout period.
- Unwilling to have a dog in the home for at least three months of time.
- Any of the following diagnoses, as identified by the intake evaluation conducted or study assessments:
- o History of any of the following mental illnesses: schizophrenia, bipolar I disorder, drug or alcohol abuse active within 6 months of study entry. Determination of these criteria will be by self-report at screening interview
- Subject has a medical condition or disorder that:
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Introduction of a dog into the homeParticipants will foster dogs from the HSSA for three months while they are in the study. | Other | Dog Introduction |
Primary outcome
Increase in positive microbiota in humans
Time frame: Seven days prior to the intervention, Day 0, Day 30, Day 60 and Day 90
To examine the degree to which the positive microbiota increase in human study participants' guts from baseline to three months. We will do this by collecting the human participants' saliva, skin and feces.
Correlation between positive microbiota changes and immune function changes
Time frame: Seven days prior to the intervention, Day 0, Day 30, Day 60 and Day 90
To examine the correlations between positive microbiota changes in the human gut after introduction of a canine companion with any changes in immune and related molecules that have been linked to emotional well-being. We will do this by collecting blood from the human participants.
16 secondary outcomes
Change in human physical activity over time
Time frame: Seven days prior to the intervention, Day 0, Days 23-30, Days 53-60 and Days 83-90
Change in dog physical activity over time
Time frame: Seven days prior to the intervention, Day 0, Days 23-30, Days 53-60 and Days 83-90
Change in heart rate variability over time
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in frailty score over time
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in body fat composition over time
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in Score on the Q-LESQ-SF (Quality of Life Enjoyment and Satisfaction Questionnaire -Short form)
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in score on the WHO-5
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in depression scores over time [Inventory of Depressive Symptomatology-Self Report (IDS-SR)]
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time Short Form-36
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the UCLA Loneliness Scale
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Mini-Cognition Test
Time frame: Day 0, Day 30, Day 60 and Day 90
Change is scores over time on the International Physical Activity Questionnaire (IPAQ)
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Dogs and Physical Activity Tool (DAPA)
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Dog Quality of Life Scale
Time frame: Day 0, Day 30, Day 60 and Day 90
Change in scores over time on the Lexington Human Animal Bond (HAB)
Time frame: Day 0, Day 30, Day 60 and Day 90
Interviews
Time frame: Day 0, Day 30, Day 60 and Day 90
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 Jan 2016.
Related trials for Health of the Human Microbiome
Enrolling by invitation
Impact of Dietary Intervention on Inflammation and Microbiome Composition Post-Colonoscopy
Colorectal Polyp, Inflammation
Active, not recruitingObservational study
Human Milk and Its Effect on Infant's Metabolism and Infant Gut Microbiome
Breast Milk Collection, Human Milk/Breastfeeding
Recruiting
The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease.
Healthy
Recruiting
Impact of Training Load on the Gut miCrobiome And Its Relation to exeRcise Performance, mUscle Phenotype, and markerS of Overreaching in Healthy Men
Exercise, Overreaching
RecruitingObservational study
Early Life Malnutrition, Environmental Enteric Dysfunction and Microbiome Trajectories
Malnutrition Pregnancy, Malnutrition in Children
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Charles Raison, MD study director
University of Arizona, Department of Psychiatry, College of Medicine
Ole Thienhaus, MD principal investigator
University of Arizona, Department of Psychiatry, College of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 2 study testing Introduction of a dog into the home in people with Health of the Human Microbiome, run by University of Arizona at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 Jan 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Increase in positive microbiota in humans (time frame: Seven days prior to the intervention, Day 0, Day 30, Day 60 and Day 90). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jan 2016.